Extended versus Standard Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Cohort Study. Aydogdu C, Urban F, Berg E, Gotz M, et al. Urol Int 2026 Jan 19:1-20. doi: 10.1159/000550580.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Aydogdu C, Urban F, Berg E, Gotz M, et al. Extended versus Standard Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Cohort Study. Urol Int 2026 Jan 19:1-20. doi: 10.1159/000550580.
PMID: 41553971